Major European pharmaceutical companies are conducting extensive preclinical research to identify and validate new drug targets and biomarkers across various cancer types. This early stage research is crucial to inform clinical development of novel oncology therapies....
Exciting oncology research is underway at several emerging European biopharmaceutical firms. Advances in cancer immunotherapies, antibody-drug conjugates, and combination therapies are highlighted in recent disclosures from these companies targeting both solid tumors...
Cancer remains one of the leading causes of death globally, with an estimated 10 million cancer deaths in 2020 alone. Major European pharmaceutical companies are continuously conducting clinical trials to develop innovative new cancer treatments and improve patient...
